Decisions 17th October 2017

At the meeting on the 17th October the following decisions were agreed

New Drug Requests


Sayana Press (TLS green)

  • For self-administered long acting contraception

Alteplase (TLS red)

  • For treatment of adult patients with iliofemoral (proximal) deep vein thrombosis (DVT) with catheter-directed thrombolysis (CDT)

Vita-POS (liquid paraffin with vitamin A eye ointment) (TLS green)

  • For long term treatment of chronic dry eye disease, or as a 'barrier' ointment used at night for recurrent erosion syndrome

Trimbow Inhaler (TLS green)

  • Beclometasone 87mcg/formoterol 5mcg/glycopyrronium 9mcg triple therapy inhaler for maintenance treatment in adult patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) not adequately treated by a combination of an inhaled corticosteroid (ICS) & long-acting.

Ribavirin (TLS red)

  • For treatment of chronic hepatitis E in post-renal transplant patients.
  • NHSE commissioned.

Shared Care Protocols/Change in TLS status


  • SCP updated

Methotrexate for RA

  • SCP update- some amendments made by group, to go back to next JFG to be signed off.


  • As per NICE TA 461
  • SCP approved for amber 3 months

Azathioprine and Mercaptopurine for IBD

  • SCP updates- further clarification around blood testing responsibilities needed. To be brought back to next JFG to be signed off.


  • TLS change from red to amber (no SCP) on advice of microbiologist

Last updated by: Emily Knight on 23-11-2017 14:40